AAAAAA

   
Results: 1-3 |
Results: 3
Vaccination with a CDR2 BV6S2/6S5 peptide in adjuvant induces peptide-specific T-cell responses in patients with multiple sclerosis
Authors: Morgan, EE Nardo, CJ Diveley, JP Kunin, J Bartholomew, RM Moss, RB Carlo, DJ
Citation: Ee. Morgan et al., Vaccination with a CDR2 BV6S2/6S5 peptide in adjuvant induces peptide-specific T-cell responses in patients with multiple sclerosis, J NEUROSC R, 64(3), 2001, pp. 298-301
Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: A phase I study
Authors: Sobol, RE Shawler, DL Carson, C Van Beveren, C Mercola, D Fakhrai, H Garrett, MA Barone, R Goldfarb, P Bartholomew, RM Brostoff, S Carlo, DJ Royston, I Gold, DP
Citation: Re. Sobol et al., Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: A phase I study, CLIN CANC R, 5(9), 1999, pp. 2359-2365
Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery tothe liver
Authors: Kwoh, DY Coffin, CC Lollo, CP Jovenal, J Banaszczyk, MG Mullen, P Phillips, A Amini, A Fabrycki, J Bartholomew, RM Brostoff, SW Carlo, DJ
Citation: Dy. Kwoh et al., Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery tothe liver, BBA-GENE ST, 1444(2), 1999, pp. 171-190
Risultati: 1-3 |